RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Neuromuscular Electric Stimulation for Chronic Obstructive Pulmonary Disease (COPD)

Q: Is NCT07910006 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

Q: What phase is NCT07910006?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Q: Can PlainTrials tell me if I qualify for NCT07910006?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

The goal of this clinical trial is to learn if targeted neuromuscular electrical stimulation (NMES) can treat respiratory and peripheral muscle weakness in patients with chronic obstructive pulmonary disease (COPD). The main questions it aims to answer are: * Does targeted NMES improve diaphragm thickening fraction and excursion as measured by diaphragm ultrasound?

Official registry: https://clinicaltrials.gov/study/NCT07910006 · Universitas Padjadjaran · enrollment listed as 45

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Neuromuscular Electric Stimulation, or Exercise. The registry lists allocation as randomized. The goal of this clinical trial is to learn if targeted neuromuscular electrical stimulation (NMES) can treat respiratory and peripheral muscle weakness in patients with chronic obstructive pulmonary disease (COPD).

They plan to enroll about 45 people at Bandung. Taking part typically means using or being fitted with a device plus check-ins.

Official title (unrewritten)

COMPARATIVE EFFECTS OF TARGETED NEUROMUSCULAR ELECTRICAL STIMULATION (NMES) ON RESPIRATORY AND PERIPHERAL MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): A MULTIMODAL ASSESSEMENT USING DIAPHRAGM ULTRASOUND AND PLASMA BIOMARKERS (IL-6 AND IGF-1)

Interventions: Neuromuscular Electric Stimulation, Exercise

Primary outcome (registry wording): Diaphragm Excursion (DE)

Who it is for (from inclusion criteria)

Ages 40 Years to 85 Years
Patients diagnosed with stable Chronic Obstructive Pulmonary Disease (COPD), GOLD spirometric grade 2-4 (post-bronchodilator FEV1/FVC \<0.70 with FEV1 \<80% predicted), confirmed by a pulmonologist
Age between 40 and 85 years old

Who the registry excludes

Recent thoracic or abdominal surgery, pneumothorax, or a history of spontaneous pneumothorax
Participation in other structured respiratory muscle training or pulmonary rehabilitation programs that may confound the study results
Presence of neuromuscular, bulbar, laryngeal, or other disorders that may independently impair respiratory muscle function
Use of a cardiac pacemaker or any metal/electronic implant at the intended stimulation area
Diagnosis of heart failure classified as NYHA (New York Heart Association) class III-IV
Presence of skin lesions, open wounds, or active dermatitis in the intended electrode placement areas
Current use of systemic (oral) corticosteroids or history of use within 4 weeks prior to enrollment

Public study contact (from the registry)

Dian Marta Sari, Physiatrist

+62 812 2181 227

dian.marta@unpad.ac.id

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

Faculty of Medicine Universitas Padjadjaran — Bandung, West Java, Indonesia (recruiting)

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseNew York, New York

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

This study wants to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters.

NCT01776398 · Official ClinicalTrials.gov record · Weill Medical College of Cornell University

RecruitingNot a traditional drug phaseLumezzane, Brescia

Not a traditional drug phase: Maximal strenght training (MST) plus endurance training (ET) for Chronic Obstructive Pulmonary Disease

In the context of pulmonary rehabilitation of COPD patients, recent guidelines and metanalysis describe that Resistance Training (RT) can be successfully performed alone or in conjunction with Endurance Training (ET) without evidence of side effects. Maximal Strength Training (MST) is a kind of RT typically performed at \~85-90% of 1RM with maximal velocity to be developed in the concentric phase.

NCT03799354 · Official ClinicalTrials.gov record · Istituti Clinici Scientifici Maugeri SpA

RecruitingNot a traditional drug phaseClermont-Ferrand

Not a traditional drug phase: Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness. for Joint Osteoarthritis

Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern.

NCT04375280 · Official ClinicalTrials.gov record · University Hospital, Clermont-Ferrand

FAQ about this NCT record

Is NCT07910006 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07910006?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07910006?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary